3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
15
Phase NA
3
Phase 1/2
2
Phase 2/3
1
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
14
Head and Neck Neoplasms
11
Glioblastoma
8
Prostatic Neoplasms
7
Carcinoma
6
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Gliosarcoma
5
Carcinoma, Non-Small-Cell Lung
5
Astrocytoma
5
Neoplasm Metastasis
4
Uterine Cervical Neoplasms
3
Neoplasms
3
Glioma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oligodendroglioma
2
Medulloblastoma
2
Lymphoma, Follicular
2
Lymphoma
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Interventions
Cisplatin
17
pembrolizumab
12
Radiotherapy
11
Nivolumab
7
Cetuximab
6
Paclitaxel
5
fludarabine
4
aldesleukin
4
Radiation
4
Interleukin-2
4
Docetaxel
4
Cyclophosphamide
4
olaparib
3
fludarabine phosphate
3
Carboplatin
3
talimogene laherparepvec
2
atezolizumab
2
Taxes
2
Sorafenib
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Capecitabine
2
Bortezomib
2
130-nm albumin-bound paclitaxel
2
vandetanib
1
tozuleristide
1
tilsotolimod
1
testosterone enanthate
1
temoporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma, Squamous Cell
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT01491139
2012-05-30
ORCA
University College, London
Phase 1
Withdrawn